Abstract
This is a Comment on Greg Myers' paper on the writing and rewriting of patent applications by two biological scientists. It draws on data from our own study of patenting in UK public sector biosciences. While agreeing with much that Myers says, we place the issues in a wider context of developing relationships between industry and academe. The emergence of new networks blurs boundaries, and makes apparently separate arenas less distinct.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
